Researchers have discovered that the protein Hmga1, found in zebrafish, can repair damaged mouse hearts by reactivating dormant genes, offering new hope for heart regeneration in humans.
Scientists from the Bakkers group at the Hubrecht Institute have achieved a major breakthrough by repairing damaged mouse hearts using a protein found in zebrafish. Their research identified the protein Hmga1 as essential for heart regeneration in zebrafish. In mice, Hmga1 successfully reactivated dormant repair genes, enabling heart recovery without harmful side effects, such as heart enlargement. Supported by the Dutch Heart Foundation and Hartekind Foundation, this groundbreaking study represents a significant advance toward developing regenerative therapies to combat heart failure. The findings were published today (January 2, 2025) in Nature Cardiovascular Research.
Zebrafish Protein Research
After a heart attack, the human heart loses millions of muscle cells that cannot regenerate, often resulting in heart failure, where the heart struggles to pump blood efficiently. Zebrafish, however, possess a remarkable ability to regrow heart muscle cells. When their heart is damaged, they can fully restore its function within 60 days.
“We don’t understand why some species can regenerate their hearts after injury while others cannot,” explains Jeroen Bakkers, the study’s leader. “By studying zebrafish and comparing them to other species, we can uncover the mechanisms of heart regeneration. This could eventually lead to therapies to prevent heart failure in humans.”
Protein-Centric Heart Repair
The research team identified a protein that enables heart repair in zebrafish. “We compared the zebrafish heart to the mouse heart, which, like the human heart, cannot regenerate,” says Dennis de Bakker, the study’s first author.
“We looked at the activity of genes in damaged and healthy parts of the heart,” he explains. “Our findings revealed that the gene for the Hmga1 protein is active during heart regeneration in zebrafish but not in mice. This showed us that Hmga1 plays a key role in heart repair.”
Typically, the Hmga1 protein is important during embryonic development when cells need to grow a lot. However, in adult cells, the gene for this protein is turned off.
Mechanisms of Gene Activation
The researchers investigated how the Hmga1 protein works. “We discovered that Hmga1 removes molecular ‘roadblocks’ on chromatin,” explains Mara Bouwman, co-first author.
Chromatin is the structure that packages DNA. When it is tightly packed, genes are inactive. When it unpacks, genes can become active again. “Hmga1 clears the way, so to say, allowing dormant genes to get back to work,” she adds.
Translating Research from Fish to Mammals
To test if the protein works similarly in mammals, the researchers applied it locally to damaged mouse hearts. “The results were remarkable: the Hmga1 protein stimulated heart muscle cells to divide and grow, significantly improving heart function,” says Bakkers. Surprisingly, cell division occurred only in the damaged area—precisely where repair was needed. “There were no adverse effects, such as excessive growth or an enlarged heart. We also didn’t see any cell division in healthy heart tissue,” Bouwman emphasizes. “This suggests that the damage itself sends a signal to activate the process.”
The team then compared the activity of the Hmga1 gene in zebrafish, mice, and humans. In human hearts, as in adult mice, the Hmga1 protein is not produced after a heart attack. However, the gene for Hmga1 is present in humans and active during embryonic development. “This provides a foundation for gene therapies that could unlock the heart’s regenerative potential in humans,” Bakkers explains.
Future Directions and Collaborative Efforts
These findings open doors for safe, targeted regenerative therapies, but there is still much work to do. “We need to refine and test the therapy further before it can be brought to the clinic,” says Bakkers. “The next step is to test whether the protein also works on human heart muscle cells in culture. We are collaborating with UMC Utrecht for this, and in 2025, the Summit program (DRIVE-RM) will begin to explore heart regeneration further.”
Emphasizing Research Collaboration
This research brought together scientists from the Hubrecht Institute and beyond. It was conducted as part of the OUTREACH consortium and funded by the Dutch Heart Foundation and Hartekind Foundation. The OUTREACH consortium is a collaboration between research institutes and all academic hospitals involved in treating patients with congenital heart defects in the Netherlands. “Normally, our group only focuses on zebrafish,” says Bouwman. “But to understand how our findings could be applied to mammals, we collaborated with the Van Rooij group and Christoffels group (Amsterdam UMC), experts in mouse research. Thanks to the Single Cell Core at the Hubrecht Institute, we were able to study heart regeneration at a detailed level.”
“We’re very lucky that we were able to set up these collaborations,” Bouwman continues. “It allows us to translate discoveries from zebrafish to mice and, hopefully, eventually to humans. We are learning so much from the zebrafish and its remarkable ability to regenerate its heart.”
Reference: “Cross-Species Comparison Reveals Hmga1 Reduces H3K27me3 Levels to Promote Cardiomyocyte Proliferation and Cardiac Regeneration” by Mara Bouwman, Dennis E.M. de Bakker, Hessel Honkoop, Alexandra E. Giovou, Danielle Versteeg, Arie R. Boender, Phong D. Nguyen, Merel Slotboom, Daniel Colquhoun, Marta Vigil-Garcia, Lieneke Kooijman, Rob Janssen, Ingeborg B. Hooijkaas, Marie Günthel, Kimberly J. Visser, Mischa Klerk, Lorena Zentilin, Mauro Giacca, Jan Kaslin, Gerard J.J. Boink, Eva van Rooij, Vincent M. Christoffels and Jeroen Bakkers, 2 January 2025, Nature Cardiovascular Research.
DOI: 10.1038/s44161-024-00588-9
Discussion about this post